Jeevandan Health is a trusted multispecialty hospital committed to delivering quality, affordable, and compassionate healthcare to the community. With advanced medical infrastructure and experienced doctors, we provide reliable treatment across major specialties including cardiology, orthopedics, neurology, and emergency care. Patients can easily connect with our team for consultations and assistance at 7070828777, ensuring timely support whenever needed. Our focus is on personalized care, accurate diagnosis, and ethical medical practices that prioritize patient safety and comfort. At Jeevandan Health, we continuously strive to raise healthcare standards while serving every patient with dedication, respect, and responsibility. Visit us :-https://share.google/6xJi7Cw34IMcjBJmS

Optic Neuropathy Management Market Trends, Opportunities & Forecast 2032 According to a newly published market research report by 24LifeSciences, global optic neuropathy management market was valued at USD 4,362 million in 2024 and is projected to reach USD 6,255 million by 2031, growing at a compound annual growth rate (CAGR) of 5.4% during the forecast period 2025–2031. Optic neuropathy encompasses a group of conditions characterized by damage to the optic nerve, which transmits visual information from the eye to the brain. These disorders, which include glaucomatous, inflammatory, and ischemic neuropathies, can lead to progressive and often irreversible vision loss if not managed effectively. The established importance of early diagnosis and intervention continues to underpin the critical need for advanced management strategies in ophthalmology and neurology. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/4366/optic-neuropathy-management-market

Global Orthostatic Hypotension Market Growth Trends and Revenue Forecast According to a newly published market research report by 24LifeSciences, global orthostatic hypotension market was valued at USD 1.36 billion in 2024 and is projected to reach USD 2.18 billion by 2031, growing at a compound annual growth rate (CAGR) of 5.9% during the forecast period 2025–2031. Orthostatic hypotension (OH), clinically defined as a reduction of systolic blood pressure of at least 20 mm Hg or diastolic blood pressure of at least 10 mm Hg within three minutes of standing, is a common cardiovascular disorder often associated with dizziness, lightheadedness, and syncope. This condition significantly impacts patient quality of life and increases fall risk, particularly in the geriatric population, with prevalence estimated at over 30% in adults aged 70 and older. Its management is crucial within neurology and cardiology, driven by its connection to neurodegenerative diseases, diabetes, and cardiovascular ailments. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/8962/orthostatic-hypotension-market